Eli Lilly recently announced that, starting from January 1, 2027, three of its drugs—Zepbound, Mounjaro, and Orforglipron—will be officially included in the coverage of Medicare Part D plans.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Oil price slump weakens Federal Reserve rate hike expectations! US bonds continue to strengthen, 10-year yield falls below 4.87%
U.S. Treasury bonds continued their upward momentum on Monday, following their largest monthly gain in over two years.
Concerns about AI investment returns continue to ferment! The Nasdaq 100 Index has entered a correction for the third time this year, falling more than 10% from its October high.
As concerns mount on Wall Street over the returns from tech giants' massive investments in artificial intelligence, the Nasdaq 100 index fell into a technical correction again on Monday.
Crypto prices
More
